Literature DB >> 25749858

How to identify hypertensive patients at high cardiovascular risk? The role of echocardiography.

Cesare Cuspidi1, Marijana Tadic, Carla Sala, Guido Grassi.   

Abstract

Scientific authorities recommend that patients with arterial hypertension should be managed not only on the basis of blood pressure (BP) levels, but also on the assemement of total cardiovascular risk. In particular, evaluation of target organ damage (TOD) is of major relevance for identifying hypertensive individuals at high cardiovascular risk independently of clinic BP levels. Evidence of cardiac and extra-cardiac TOD has been consistently associated with worse cardiovascular prognosis. Unfortunately, detection of TOD markedly depends on sensitivity of diagnostic tools, at difference from evaluation of risk factors and associated diseases, usually reliably provided by accurate clinical examination and routine investigation. The purpose of this paper was to provide an updated, comprehensive review on the role of echocardiography in identifying hypertensive patients apparently uncomplicated, but exposed to a high cardiovascular risk due to the presence of subclinical structural and functional cardiac alterations of adverse prognostic significance.

Entities:  

Mesh:

Year:  2015        PMID: 25749858     DOI: 10.1007/s40292-015-0079-2

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  42 in total

1.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors: 
Journal:  J Hypertens       Date:  1999-02       Impact factor: 4.844

2.  Prognostic value of left ventricular mass normalized to different body size indexes: findings from the PAMELA population.

Authors:  Cesare Cuspidi; Rita Facchetti; Michele Bombelli; Carla Sala; Marijana Tadic; Guido Grassi; Giuseppe Mancia
Journal:  J Hypertens       Date:  2015-05       Impact factor: 4.844

3.  Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.

Authors:  K Wachtell; G Smith; E Gerdts; B Dahlöf; M S Nieminen; V Papademetriou; J N Bella; H Ibsen; J Rokkedal; R B Devereux
Journal:  Am J Cardiol       Date:  2000-02-15       Impact factor: 2.778

4.  Left atrial size and the risk of ischemic stroke in an ethnically mixed population.

Authors:  M R Di Tullio; R L Sacco; R R Sciacca; S Homma
Journal:  Stroke       Date:  1999-10       Impact factor: 7.914

Review 5.  Prevalence of echocardiographic left-atrial enlargement in hypertension: a systematic review of recent clinical studies.

Authors:  Cesare Cuspidi; Marta Rescaldani; Carla Sala
Journal:  Am J Hypertens       Date:  2013-02-06       Impact factor: 2.689

6.  Prevalence of left ventricular hypertrophy in patients with mild hypertension in primary care: impact of echocardiography on cardiovascular risk stratification.

Authors:  María A Martinez; Teresa Sancho; Eduardo Armada; José M Rubio; José L Antón; Alberto Torre; Javier Palau; Paloma Seguido; Jaime Gallo; Isabel Saenz; Enrique Polo; Rosa Torres; José Oliver; Juan G Puig
Journal:  Am J Hypertens       Date:  2003-07       Impact factor: 2.689

7.  Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients.

Authors:  Maria Lorenza Muiesan; Massimo Salvetti; Cristina Monteduro; Bianca Bonzi; Anna Paini; Sara Viola; Paolo Poisa; Damiano Rizzoni; Maurizio Castellano; Enrico Agabiti-Rosei
Journal:  Hypertension       Date:  2004-03-08       Impact factor: 10.190

8.  Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.

Authors:  S M Vaziri; M G Larson; E J Benjamin; D Levy
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

9.  Prognostic significance of left atrial enlargement in a general population: results of the PAMELA study.

Authors:  Michele Bombelli; Rita Facchetti; Cesare Cuspidi; Paolo Villa; Dario Dozio; Gianmaria Brambilla; Guido Grassi; Giuseppe Mancia
Journal:  Hypertension       Date:  2014-09-08       Impact factor: 10.190

10.  Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.

Authors:  Alessandra Meris; Maria Amigoni; Hajime Uno; Jens Jakob Thune; Anil Verma; Lars Køber; Mikhail Bourgoun; John J McMurray; Eric J Velazquez; Aldo P Maggioni; Jalal Ghali; J Malcolm O Arnold; Steven Zelenkofske; Marc A Pfeffer; Scott D Solomon
Journal:  Eur Heart J       Date:  2008-11-11       Impact factor: 29.983

View more
  2 in total

1.  Evaluation of aortic stiffness by a new simplified 2D speckle tracking analysis.

Authors:  Luca Sabia; Eleonora Avenatti; Marco Cesareo; Dario Leone; Francesco Tosello; Franco Veglio; Alberto Milan
Journal:  Int J Cardiovasc Imaging       Date:  2018-06-21       Impact factor: 2.357

2.  sRAGE and early signs of cardiac target organ damage in mild hypertensives.

Authors:  Andrea Maria Maresca; Luigina Guasti; Sara Bozzini; Christian Mongiardi; Nicolò Tandurella; Rossana Corso; Francesco G Zerba; Alessandro Squizzato; Leonardo Campiotti; Francesco Dentali; Catherine Klersy; Anna M Grandi; Colomba Falcone
Journal:  Cardiovasc Diabetol       Date:  2019-02-12       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.